Target intelligence / Profile preview

novel transcript, sense intronic to CDK6

Molecular classification
Other (likely long non-coding RNA or uncharacterized RNA, not classified as enzyme, receptor, transporter, etc.)
01

Overview

ENSG00000287932 is a GENCODE-annotated uncharacterized "novel transcript, sense intronic to CDK6", also referred to as AC000065.2, and corresponds to a non-protein-coding RNA transcribed from within the intronic region of the CDK6 gene on chromosome 7[3]. This transcript is not equivalent to the canonical protein-coding CDK6 (cyclin-dependent kinase 6) gene, for which robust therapeutic targeting, biological function, and disease roles are well established[3][5]. There is currently no publicly available functional or clinical information for this non-coding transcript, and it is not considered a therapeutic target. Key context: - Is it a therapeutic target? No; protein-coding CDK6 is a well-validated cancer target, but this specific transcript is not[3][5]. - Is something wrong with this target? Yes; it is not a well-defined or actionable molecular target, and may be a generic or placeholder description from a transcriptomics dataset[3]. - Aliases: Sometimes referred to by its genome annotation (e.g., AC000065.2)[3]. Note: If you are seeking information on the canonical CDK6 protein ("cyclin-dependent kinase 6"), that is a very different, well-characterized kinase involved in cell cycle control and oncogenesis[2][5][6]. The current identifier (ENSG00000287932) and description refer specifically to a non-coding RNA, not the kinase enzyme.

Other names
AC000065.2

Beyond the preview

Go deeper on novel transcript, sense intronic to CDK6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, sense intronic to CDK6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call